|
|
|
Welcome to the Quality Counts. For those health conscious consumers and medical professionals that are looking to purchase nutritional supplements, vitamins, herbs, learning about medications, losing weight, health food, low carbs, high protein nutrition, and exercise, you have come to the right place. Quality Counts serves both the medical practitioner and consumer interested in nutritional therapy and alternative medicine.
Home > Health Conditions > Ovarian Cancer > Doxil
(doxorubicin HCL)
Doxil® (doxorubicin HCl)
Related Topics:
News & Research:
-
Viagra Prevents Anti-Cancer Drug Induced Heart Damage - Doctor's Guide,
4/5/05
-
FDA Grants Full Approval to Doxil (Doxorubicin), Treatment for Progression or Recurrence of Ovarian Cancer - Doctor's Guide, 2/7/05
-
Pegylated and Nonpegylated Liposomal Doxorubicin Reduce Risk of Cardiotoxicity - Doctor's Guide, 6/24/04
-
Study Compares Doxil/Caelyx (Doxorubicin HCL Liposome Injection) to Doxorubicin for First-Line Treatment of Metastatic Breast Cancer - Doctor's Guide, 5/20/04
-
Sequential, Alternating, or Combination Doxorubicin/Docetaxel Regimens Appear Equally Effective in Metastatic Breast Cancer, However, Combination is More Toxic - Doctor's Guide,
4/16/04
- Efficacy of Doxorubicin and Docetaxel in Treatment of Metastatic Breast Cancer Appears Independent of Administration Schedule - Doctor's Guide, 4/15/04
- Docetaxel-Doxorubicin Dose-Dense Sequential Treatment Prolongs Survival in Stage II and III Breast Cancer - Doctor's Guide, 2/16/04
- Combination Doxorubicin and Gemcitabine Shows Promise in Recurrent Ovarian Cancer - Doctor's Guide, 2/13/04
- Women with Node-Positive, Hormone-Receptor Negative Breast Cancer Do Not Benefit From Doxorubicin - Doctor's Guide, 11/19/03
- Combination Pegylated Liposomal Doxorubicin/ Gemcitabine Is Effective, Safe For Metastatic Breast Cancer - Doctor's Guide, 9/11/03
- Pegylated Liposomal Doxorubicin Has Important Clinical Utility in Breast Cancer - Doctor's Guide, 8/8/03
- Sequential Doxorubicin and Docetaxel Less Toxic and as Effective as Concomitant Therapy - Doctor's Guide, 6/3/03
-
Cancer Drug's Heart Risk Underestimated - HealthDay, 5/19/03
- Combination Therapy With Doxil (Doxorubicin) Encouraging In Treating Newly Diagnosed Multiple Myeloma Patients - Doctor's Guide, 5/8/03
- Dose-Dense Chemotherapy Regimen Shows Promise In Breast Cancer - Doctor's Guide, 11/18/02
- Less Cardiac Risk, Toxicity With Reformulated Doxorubicin For Metastatic Breast Cancer - Doctor's Guide, 1/14/02
- Doxil Approved For Refractory Ovarian Cancer - Doctor's Guide, 6/29/99
- FDA Advisors Recommend Doxil For Refractory Ovarian Cancer - Doctor's Guide, 6/8/99
Related Searches:
70701
|